/

Other

/

Norgine

Norgine

Norgine

Verified Nov 2026

Other

·

Amsterdam, North Holland

·

Since 1906

Norgine is a specialty pharmaceutical and consumer healthcare company headquartered in Amsterdam, Netherlands, founded in 1906. The company employs 1,000–5,000 people and generates €500 million–€1 billion in annual revenue. It develops and manufactures branded drugs and medical devices for gastroenterology, hepatology, cancer care, and women's health, serving more than 25 million patients annually across Western Europe, Australia, and New Zealand. In March 2026, Norgine committed over £50 million to expand medicines manufacturing in Wales.

Norgine

Verified Nov 2026

AT A GLANCE

Founded

1906

Headquarters

Amsterdam, North Holland

Employees

1,000-5,000

Ownership

Norgine at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

1906

Headquarters

Amsterdam, North Holland

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Norgine is a specialty pharmaceutical and consumer healthcare company headquartered in Amsterdam, Netherlands, founded in 1906. The company employs 1,000–5,000 people and generates €500 million–€1 billion in annual revenue. It develops and manufactures branded drugs and medical devices for gastroenterology, hepatology, cancer care, and women's health, serving more than 25 million patients annually across Western Europe, Australia, and New Zealand. In March 2026, Norgine committed over £50 million to expand medicines manufacturing in Wales.

At a glance

Attribute

Detail

Founded

1906

Headquarters

Amsterdam, North Holland

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

What Norgine makes

The company operates integrated manufacturing facilities in Hengoed, Wales, and Dreux, France, and develops a portfolio spanning gastroenterology, hepatology, cancer care, and women's health therapeutics.

Latest developments

Facilities

Norgine is headquartered in Amsterdam, North Holland. Public sources also reference these locations:

Company details

Norgine completed the acquisition of Theravia in August 2025 and holds an exclusive commercial license from Vir Biotechnology for a chronic hepatitis delta treatment candidate in Europe, Australia, and New Zealand. Norgine was founded in 1906, has an estimated 1,000-5,000 employees, and is headquartered in Amsterdam, North Holland.

Frequently asked questions

What does Norgine do?

Norgine is a specialty pharmaceutical and consumer healthcare company headquartered in Amsterdam, Netherlands, founded in 1906. The company employs 1,000–5,000 people and generates €500 million–€1 billion in annual revenue. It develops and manufactures branded drugs and medical devices for gastroenterology, hepatology, cancer care, and women's health, serving more than 25 million patients annually across Western Europe, Australia, and New Zealand. In March 2026, Norgine committed over £50 million to expand medicines manufacturing in Wales.

Where is Norgine headquartered?

Norgine is headquartered in Amsterdam, North Holland (150 Antonio Vivaldistraat, Amsterdam, North Holland, 1083 HP).

When was Norgine founded?

Norgine was founded in 1906.

How big is Norgine?

Norgine has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Amsterdam, North Holland (HQ)Headquarters · HP, Netherlands
Amsterdam, North Holland (HQ)150 Antonio Vivaldistraat, Amsterdam, North Holland, 1083 HP, NetherlandsHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.